Skip to main content

Table 9 Mental health

From: Benefits and harms of medical cannabis: a scoping review of systematic reviews

Author, year {refid}

Search dates; # databases searched

Funding source

Nstudies

Illness/condition

Intervention/comparator

Outcomes

Conclusions from data

AMSTAR-2 rating

Walsh, 2017 [19]

1960–Sept 2015; 2

Government

31

Mental health

I: Plant-derived cannabinoids

C: Cannabinoid with no THC

• Improvement in anxiety and depression

Only one RCT included (combined with cross-sectional data)

CL

O’Neil, 2017 [33]

Inception–Mar 2017; 6

Government

5

PTSD

I: All types of cannabinoids

C: Different dose or different duration of dose of cannabinoids

N/A observational data

N/A observational data

M

McLoughlin, 2014 [45]

To Aug 12, 2013; 6

Non-profit

1

Schizophrenia

I: Plant-derived cannabinoids

C: Amisulpride

• Mental state outcomes

Only one study included

H

  1. PTSD posttraumatic stress disorder, SBS study-by-study